Here are the DEF 14A proxy statements from Incannex Healthcare Limited (IXHL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow IXHL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IXHL filings page.
Incannex Healthcare Inc. asks stockholders to elect Joel Latham and Troy Valentine as Class III directors for three-year terms ending at the 2029 annual meeting and to ratify Grant Thornton Audit Pty Ltd as its independent registered public accounting firm for the fiscal year ending June 30, 2027. The board recommends both proposals. The virtual annual meeting is scheduled for December 17, 2026, at 10:00 a.m. Gulf Standard Time, with attendance by live audio webcast after advance registration. Common stockholders of record on October 22, 2026, may vote; 12,544,627 shares were outstanding and entitled to vote on that date, with one vote per share.
Reported fiscal 2026 total compensation was $6,527,200 for Chief Executive Officer Joel Latham, including $5,200,000 in stock awards, and $466,456 for Chief Financial Officer Joseph Swan. Grant Thornton audit fees were $335,885 for fiscal 2026 and $307,852 for fiscal 2025.